Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat*

Human immunodeficiency virus, type 1 (HIV-1) is the etiological agent for the acquired immunodeficiency syndrome (AIDS). HIV-1 is a retrovirus that encodes a small nuclear transcriptional activator protein, Tat (Fig. 1). In vivo, Tat is required for virus replication and is conserved in the genomes of all primate lentiviruses (1). Over the past decade, the transcriptional function(s) of Tat (reviewed in detail several years ago (2)) has been intensely investigated. It has become clear that a primary role for Tat is in regulating productive and processive transcription from the HIV-1 long terminal repeat (LTR). Tat also has other activities; some are consistent with that of a secreted growth factor (3–5) and a potentiator of reverse transcription (6). Here we review recent insights into the multifaceted activities of Tat.

[1]  K. Jeang,et al.  Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1* , 1996, The Journal of Biological Chemistry.

[2]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.

[3]  D. Price,et al.  Control of formation of two distinct classes of RNA polymerase II elongation complexes , 1992, Molecular and cellular biology.

[4]  H. Xiao,et al.  Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment , 1997, Molecular and cellular biology.

[5]  M. Malim,et al.  Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein , 1989, Journal of virology.

[6]  F. Carlotti,et al.  Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins , 1990, Journal of virology.

[7]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[8]  T. Rana,et al.  Tat-associated Kinase (P-TEFb): a Component of Transcription Preinitiation and Elongation Complexes* , 1999, The Journal of Biological Chemistry.

[9]  B. Berkhout,et al.  A Second-Site Mutation That Restores Replication of a Tat-Defective Human Immunodeficiency Virus , 1999, Journal of Virology.

[10]  C. Van Lint,et al.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. , 1993, The EMBO journal.

[11]  T. Mak,et al.  Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat). , 1992, Nucleic Acids Research.

[12]  J. Karn,et al.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Gralla,et al.  Transcription reinitiation rate: a potential role for TATA box stabilization of the TFIID:TFIIA:DNA complex. , 1999, Nucleic acids research.

[14]  R. Gaynor,et al.  Tat is required for efficient HIV‐1 reverse transcription , 1997, The EMBO journal.

[15]  A. Srinivasan,et al.  Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. , 1989, Nucleic acids research.

[16]  D. Derse,et al.  Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras , 1991, Journal of virology.

[17]  D. Reinberg,et al.  The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme , 1997, Molecular and cellular biology.

[18]  N. Sonenberg,et al.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. , 1990, Disease markers.

[19]  T. Nguyen,et al.  Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Kashanchi,et al.  Direct interaction of human TFIID with the HIV-1 transactivator Tat , 1994, Nature.

[21]  J. Karn,et al.  Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type‐1 transcription elongation complex , 1997, The EMBO journal.

[22]  T. Rana,et al.  Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. , 1999, Archives of biochemistry and biophysics.

[23]  A. Rice,et al.  TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Ruben,et al.  Structural and functional characterization of human immunodeficiency virus tat protein , 1989, Journal of virology.

[25]  J. Karn,et al.  High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. , 1993, Journal of molecular biology.

[26]  P. Jalinot,et al.  Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. , 1997, The Journal of general virology.

[27]  Natalie A. Lissy,et al.  Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein , 1999, Nature Medicine.

[28]  X. Y. Li,et al.  The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. , 1998, Genes & development.

[29]  R. Roeder,et al.  Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain , 1996, Nature.

[30]  B. Peterlin,et al.  Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR , 1993, Journal of virology.

[31]  H. Xiao,et al.  Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. , 1998, Biochemical and biophysical research communications.

[32]  A. Rice,et al.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor , 1995, Journal of virology.

[33]  C. Rosen,et al.  A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. , 1990, Science.

[34]  D. Singer,et al.  Repression of MHC class I gene promoter activity by two-exon Tat of HIV. , 1993, Science.

[35]  J. Karn,et al.  Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Jeang,et al.  Epithelin/granulin growth factors: extracellular cofactors for HIV-1 and HIV-2 Tat proteins. , 1999, Biochemical and biophysical research communications.

[37]  D. Crothers,et al.  RNA recognition by Tat-derived peptides: Interaction in the major groove? , 1991, Cell.

[38]  K. Struhl,et al.  Connecting a promoter-bound protein to TBP bypasses the need for a transcriptional activation domain , 1995, Nature.

[39]  B. Peterlin,et al.  Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs. , 1993, Virology.

[40]  B. Berkhout,et al.  Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat , 1992, Journal of virology.

[41]  J. Lis,et al.  Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation , 1994, Nature.

[42]  R. Young,et al.  CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription , 1997, Molecular and cellular biology.

[43]  V. Metelev,et al.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.

[44]  R. Roeder,et al.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. , 1992, Genes & development.

[45]  M. Garcia-Blanco,et al.  Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex. , 1999, Virology.

[46]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[47]  G. Goldstein HIV–1 Tat protein as a potential AIDS vaccine , 1996, Nature Medicine.

[48]  G. Nabel,et al.  Interaction of Human Immunodeficiency Virus Type 1 Tat with the Transcriptional Coactivators p300 and CREB Binding Protein , 1998, Journal of Virology.

[49]  J. Mullins,et al.  Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1 , 1988, Journal of virology.

[50]  D. Reinberg,et al.  Common themes in assembly and function of eukaryotic transcription complexes. , 1995, Annual review of biochemistry.

[51]  K. Jeang,et al.  Human immunodeficiency viruses regulated by alternative trans‐activators: genetic evidence for a novel non‐transcriptional function of Tat in virion infectivity. , 1994, The EMBO journal.

[52]  K. Jeang,et al.  Activation of Integrated Provirus Requires Histone Acetyltransferase , 1998, The Journal of Biological Chemistry.

[53]  R. Gaynor,et al.  Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[55]  D. Hudson,et al.  Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. , 1991, Genes & development.

[56]  R. Gaynor,et al.  Functional Domains of Tat Required for Efficient Human Immunodeficiency Virus Type 1 Reverse Transcription , 1999, Journal of Virology.

[57]  Andreas Meyerhans,et al.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.

[58]  D. Chen,et al.  Tat Activates Human Immunodeficiency Virus Type 1 Transcriptional Elongation Independent of TFIIH Kinase , 1999, Molecular and Cellular Biology.

[59]  K. Jeang,et al.  Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat , 1998, Journal of Virology.

[60]  E. Blair,et al.  A simple and rapid TAR-dependent in vitro transcription assay using T cell nuclear extracts and synthetictat1-86 protein , 1995 .

[61]  Phillip A. Sharp,et al.  HIV-1 Tat protein trans-activates transcription in vitro , 1990, Cell.

[62]  B. Berkhout,et al.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target , 1989, Cell.

[63]  R. Gaynor,et al.  Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes* , 1997, The Journal of Biological Chemistry.

[64]  Julie A. Brown,et al.  HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Singh,et al.  HIV‐1 tat protein stimulates transcription by binding to a U‐rich bulge in the stem of the TAR RNA structure. , 1990, The EMBO journal.

[66]  K. Schulze-Osthoff,et al.  HIV‐1 Tat potentiates TNF‐induced NF‐kappa B activation and cytotoxicity by altering the cellular redox state. , 1995, The EMBO journal.

[67]  H. Okamoto,et al.  Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  K. Jeang,et al.  In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor , 1993, Journal of virology.

[69]  B. Peterlin,et al.  A minimal lentivirus Tat , 1991, Journal of virology.

[70]  C. Van Lint,et al.  Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.

[71]  H. Xiao,et al.  Recruiting TATA-binding protein to a promoter: transcriptional activation without an upstream activator , 1995, Molecular and cellular biology.

[72]  B. Berkhout,et al.  Effects of integration and replication on transcription of the HIV-1 long terminal repeat. , 1993, The Journal of biological chemistry.

[73]  R. Gaynor,et al.  Functional domains required for tat‐induced transcriptional activation of the HIV‐1 long terminal repeat. , 1988, The EMBO journal.

[74]  N. Marshall,et al.  Regulation of Carboxyl-terminal Domain Phosphatase by HIV-1 Tat Protein* , 1998, The Journal of Biological Chemistry.

[75]  S. Josephs,et al.  Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[76]  B. Berkhout,et al.  Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. , 1992, The Journal of biological chemistry.

[77]  D. Chen,et al.  Transcription elongation factor P‐TEFb mediates Tat activation of HIV‐1 transcription at multiple stages , 1998, The EMBO journal.

[78]  D. Olive,et al.  Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants , 1999, The Journal of Biological Chemistry.

[79]  J. Greenblatt,et al.  A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  K. Jeang,et al.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture , 1996, Journal of virology.

[81]  F. Carlotti,et al.  Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein , 1990, Journal of virology.

[82]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[83]  M. Giacca,et al.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[84]  R. Rabin,et al.  HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  B. Berkhout,et al.  On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. , 1998, AIDS research and human retroviruses.

[86]  T. Mak,et al.  HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.

[87]  R. Gallo,et al.  Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. , 1995, Journal of biomedical science.

[88]  M. Dahmus Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II* , 1996, The Journal of Biological Chemistry.